Effects of Zoledronic Acid on Growth of Human Lung Adenocarcinoma Cell Line A549 in Vitro

YANG Zhen-hua,SHU Yong-qian,SHAO Qian-wen

DOI: https://doi.org/10.3969/j.issn.1007-4368.2006.09.022

2006-01-01

Abstract:Objective:To evaluate the effects of zoledronic acid on growth of human lung adenocarcinoma cell line A549,and to investigate whether this effect was mediated by induction of cell cycle arrest or apoptosis and whether there was a synergistic interaction between zoledronic acid and cisplatin.Methods:Zoledronic acid alone or combined with anticancer drug cisplatin were used to treat human lung adenocarcinoma A549 cell line.The cell growth inhibition and cell cycle apoptosis were assessed by MTT and flow cytometry.Results:There was a dose-dependent and time-dependent(1～200 μmol/L)inhibition of cell proliferation by zoledronic acid.IC50 value of zoledronic acid for therapy of A549 after 72 h was 25 μmol/L.The cell growth inhibition rate of A549 after 72 h was(13.58 ± 3.13)% in cisplatin(0.5 mg/L)group,and(20.69 ± 2.69)% and(44.05 ± 4.03)% in zoledronic acid groups(1 μmol/L,10 μmol/L).When combined treatment of zoledronic acid(1 μmol/L,10 μmol/L)and cisplatin(0.5 mg/L)was used,the cell growth inhibition rates were(44.23 ± 3.77)% and(60.9 ± 3.03)%,respectively.These differences were significant(P 0.01).The apoptotic rate of A549 cells induced by cisplatin(0.5 mg/L)was(9.08 ± 1.31)%,and that induced by zoledronic acid(1 μmol/L,10 μmol/L)was(16.94 ± 1.95)% and(24.03 ± 0.44)%,respectively.The apoptotic rate was(32.22 ± 1.68)% or(39.22 ± 7.00)% after combined treatment of zoledronic acid(1 μmol/L or 10 μmol/L)and cisplatin(0.5 mg/L).Conclusion:Zoledronic acid has an explicit effect of inhibiting proliferation of A549 cells in a time-and dose-dependent manner.Its IC50 value is 25 μmol/L.Zoledronic acid could induce apoptosis,and has a synergistic interaction with cisplatin.